These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19147607)

  • 1. Antihypertensive drugs in daily clinical practice: are there differences between genders?
    Barrios V; Escobar C; Echarri R; Jimenez-Nacher JJ
    Eur Heart J; 2009 Mar; 30(5):624. PubMed ID: 19147607
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes for new anti-hypertensives in the elderly.
    Johnson KH; Chappelle CM
    J Fam Pract; 2000 Feb; 49(2):111, 183. PubMed ID: 10718686
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antihypertensive therapy].
    Schmieder RE; Veelken R
    MMW Fortschr Med; 2009 Apr; 151(14):95-8; quiz 99. PubMed ID: 19504848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significant reduction in mortality and cardiovascular events in patients aged 80 and over when treated with hypertensive agents].
    Rev Med Suisse; 2008 Jun; 4(160):1412. PubMed ID: 18630065
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood pressure limits for beginning and goal of antihypertensive therapy (3). What is not proven but plausible?].
    Holzgreve H
    MMW Fortschr Med; 2005 Jul; 147(27-28):39-40. PubMed ID: 16041940
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensive treatment in the very elderly shows significant mortality benefit.
    Cardiovasc J Afr; 2008; 19(3):169-71. PubMed ID: 18568185
    [No Abstract]   [Full Text] [Related]  

  • 7. Study shows benefit of hypertension help after 80.
    Johns Hopkins Med Lett Health After 50; 2008 Sep; 20(7):7. PubMed ID: 18822530
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypertension, physician's honour and TV].
    Nilsson PM
    Lakartidningen; 2003 Nov; 100(48):4010. PubMed ID: 14717097
    [No Abstract]   [Full Text] [Related]  

  • 9. Are guidelines effectively guiding antihypertensive therapy?
    Vasan RS; Kannel WB
    Am J Cardiol; 2007 Jul; 100(1):143-4. PubMed ID: 17599457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Threshold and target blood pressures for treating hypertension. The facts].
    Holzgreve H
    MMW Fortschr Med; 2005 Apr; 147(15):45-6. PubMed ID: 15884503
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is blood pressure treatment as effective in the population as in controlled trials?].
    Kjeldsen SE
    Tidsskr Nor Laegeforen; 1995 Jan; 115(1):102-3. PubMed ID: 7846647
    [No Abstract]   [Full Text] [Related]  

  • 12. Gender and the response to blood pressure-lowering treatment.
    Lip GY; Butt M
    Eur Heart J; 2008 Nov; 29(21):2585-6. PubMed ID: 18852182
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes and hypertension: which is the best approach?
    Escobar C; Barrios V
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):269-71. PubMed ID: 19296764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What we really need to do to reduce cardiovascular events in hypertensive patients.
    Ong HT
    J Fam Pract; 2007 Sep; 56(9):727-34. PubMed ID: 17764644
    [No Abstract]   [Full Text] [Related]  

  • 15. [Has the HOT study taught us something new?].
    Thelle DS
    Tidsskr Nor Laegeforen; 1999 Jan; 119(3):353. PubMed ID: 10074827
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast carcinoma and antihypertensive therapy.
    Giordano SH
    Cancer; 2003 Oct; 98(7):1334-6. PubMed ID: 14508818
    [No Abstract]   [Full Text] [Related]  

  • 17. [Absolute cardiovascular risk or hypertension?].
    Beaufils M
    Arch Mal Coeur Vaiss; 2006; 99(7-8):659. PubMed ID: 17061438
    [No Abstract]   [Full Text] [Related]  

  • 18. [Uneven sex distribution in the cardiovascular trials--an exaggerated problem].
    Melander H; Rastad JA
    Lakartidningen; 2006 Jun 8-13; 103(23):1856-9. PubMed ID: 16838599
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.